Skip to main content
. 2021 Mar 31;6(14):9442–9448. doi: 10.1021/acsomega.0c06066

Figure 2.

Figure 2

Feprazone increased telomerase activity in IL-1β-challenged C-28/I2 chondrocytes. Cells were stimulated with IL-1β (10 ng/mL) in the presence or absence of Feprazone (10 and 20 μM) for 14 days. Telomerase activity (n = 5 or 6; ###, P < 0.001 vs the vehicle group; &, P < 0.05 vs the IL-1β group; &&, P < 0.01 vs the IL-1β group) was assayed.